acyclovir

Product NDC: 70934-132
11-digit product format: 709340132
Labeler code: 70934
Product ID: 70934-132_dc10ec8b-0330-095a-e053-2a95a90afcd1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: acyclovir
Dosage form: TABLET
Route: ORAL
Labeler: Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Application: ANDA204314
Marketing category: ANDA
Marketing start: 2018-06-06
Marketing end: 0000-00-00
Substance: ACYCLOVIR
Active strength: 800 mg/1
Pharmacologic classes: DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
70934-132-35	EA - Each	70934-132	9345fcc2-490d-4ce9-9b49-0cef4acd9466	1	2018-09-05

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X4HES1O11F	ACYCLOVIR	59277-89-3	ACYCLOVIR

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70934-132-30	70934013230	30 TABLET in 1 BOTTLE, PLASTIC (70934-132-30)	30 tablet	2022-04-07	0000-00-00	No	No	Current
70934-132-35	70934013235	35 TABLET in 1 BOTTLE, PLASTIC (70934-132-35)	35 tablet	2018-06-06	0000-00-00	No	No	Current